// App-Quantinova.ai

Abstract 11537 : Progress Towards a Proteomic Surrogate Endpoint for Cardiovascular Outcomes

Researchers

Presenter

  • Stephen A Williams

Principal Investigators

  • Michael Hinterberg

  • Josef Coresh

  • Christie M Ballantyne

  • Kunihiro Matsushita

  • Christian Mueller

  • Joan E Walter

  • Christian Jonasson

  • Rury H Holman

  • Svati H Shah

  • Naveed Sattar

  • Roy Taylor

  • Michael Lean

  • Shintaro Kato

  • Hiroaki Shimokawa

  • Yasuhito Sakata

  • Kotaro Nochioka

  • Chirag Parikh

  • Steven Coca

  • Torbjoern Omland

  • Jessica Chadwick

  • David Astling

  • Yolanda Hagar

  • Natasha Kurieski

  • Jeremy Primus

  • Missy Simpson

  • Nelson P Trujillo

  • Peter Ganz

Medical Centers

  • UNIVERSITY OF GLASGOW, Glasgow

  • Johns Hopkins University, Baltimore, MD

  • DUKE UNIV MEDICAL CENTER, Hillsborough, NC

  • SomaLogic, Boulder, CO

  • SOMALOGIC INC, Boulder, CO

  • University of Newcastle, Newcastle, United Kingdom,

  • University of Glasgow, Glasgow, United Kingdom

  • AKERSHUS UNIVERSITY HOSPITAL, Lorenskog, Norway

  • JOHNS HOPKINS SPH WELCH CENTER, Baltimore, MD

  • International Univ of Health and W, Narita City

  • Univ Hosp Basel, Basel

  • NEC Solution Innovators Ltd, Tokyo, Japan

  • SomaLogic, Boulder, CO

  • Norwegian University of Science and Technology, Trondheim, Norway

  • Univ. of Basel, Basel, Switzerland

  • Diabetes Trials Unit, Radcliffe Dept of Medicine, Univ of Oxford, Oxford, United Kingdom

  • SAN FRANCISCO GENERAL HOSP, San Francisco, CA

  • Tohoku University School of Medicine, Sendai, Japan

  • TOHOKU UNIVERSITY, Sendai

  • BAYLOR COLLEGE OF MEDICINE, Houston, TX

  • ROCKY MOUNTAIN CARDIOLOGY PC, Boulder, CO

Locations

  • United Kingdom

  • United States

  • Norway

  • Switzerland

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Congestive heart failure

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A